The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
Proton pump inhibitors (PPIs) are the mainstay of therapy for all gastric acid related diseases and are commonly used in current clinical practice. Although widely regarded as safe, PPIs have been associated with a variety of adverse effects, including hypomagnesaemia. The postulated mechanism of P...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
ASEAN Federation of Endocrine Societies
2020-04-01
|
| Series: | Journal of the ASEAN Federation of Endocrine Societies |
| Subjects: | |
| Online Access: | https://asean-endocrinejournal.org/index.php/JAFES/article/view/727 |